The potential of microelectrode arrays and microelectronics for biomedical research and diagnostics

Anal Bioanal Chem. 2011 Mar;399(7):2313-29. doi: 10.1007/s00216-010-3968-1. Epub 2010 Jul 31.

Abstract

Planar microelectrode arrays (MEAs) are devices that can be used in biomedical and basic in vitro research to provide extracellular electrophysiological information about biological systems at high spatial and temporal resolution. Complementary metal oxide semiconductor (CMOS) is a technology with which MEAs can be produced on a microscale featuring high spatial resolution and excellent signal-to-noise characteristics. CMOS MEAs are specialized for the analysis of complete electrogenic cellular networks at the cellular or subcellular level in dissociated cultures, organotypic cultures, and acute tissue slices; they can also function as biosensors to detect biochemical events. Models of disease or the response of cellular networks to pharmacological compounds can be studied in vitro, allowing one to investigate pathologies, such as cardiac arrhythmias, memory impairment due to Alzheimer's disease, or vision impairment caused by ganglion cell degeneration in the retina.

Publication types

  • Review

MeSH terms

  • Animals
  • Biosensing Techniques / instrumentation
  • Cell Culture Techniques
  • Drug Evaluation, Preclinical / methods
  • Drug Interactions
  • Electrochemical Techniques / instrumentation*
  • Electrochemical Techniques / trends
  • Electrophysiological Phenomena
  • High-Throughput Screening Assays / instrumentation
  • Humans
  • Microarray Analysis / instrumentation*
  • Microarray Analysis / methods
  • Microarray Analysis / trends
  • Microelectrodes*
  • Myocytes, Cardiac / physiology
  • Neurons / physiology
  • Retinal Ganglion Cells / physiology
  • Semiconductors / instrumentation*